Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Lefamulin Acetate CAS 1350636-82-6 Active Pharma Ingredient C30H49NO7S

Lefamulin Acetate CAS 1350636-82-6 Active Pharma Ingredient C30H49NO7S

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1350636-82-6

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

Lefamulin Acetate CAS 1350636-82-6

,

CAS 1350636-82-6 Active Pharma Ingredient

,

C30H49NO7S Lefamulin Acetate

CAS NO::
1350636-82-6
Appearance::
White To Off-white Solid
Molecular Formula::
C30H49NO7S
Molecular Weight::
567.778
EINECS NO::
695-920-8
MDL NO::
NA
CAS NO::
1350636-82-6
Appearance::
White To Off-white Solid
Molecular Formula::
C30H49NO7S
Molecular Weight::
567.778
EINECS NO::
695-920-8
MDL NO::
NA
Lefamulin Acetate CAS 1350636-82-6 Active Pharma Ingredient C30H49NO7S

Product Description:

Product Name: Lefamulin acetate CAS NO:1350636-82-6

 

 

 

Synonyms:

14-O-{[(1R,2R,4R)-4-amino-2-hydroxy-cyclohexylsulfanyl]-acetyl}-mutilin acetate

 

 

 

Chemical & Physical Properties:

Appearance: White to off-white Solid

Assay :≥98.0%

Solubility: Soluble in DMSO

 

 

 

Lefamulin acetate (BC-3781 acetate) is an orally active antibiotic for community-acquired bacterial pneumonia (CABP) treatment. Lefamulin acetate (BC-3781 acetate) is the first semi-synthetic pleuromutilin for systemic treatment of bacterial infections in humans. Lefamulin acetate (BC-3781 acetate) inhibits protein synthesis by binding to the peptidyl transferase center of the 50S bacterial ribosome, preventing the binding of transfer RNA for peptide transfer.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.